HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Computer-aided design of short peptide ligands targeting tumor necrosis factor-alpha for adsorbent applications.

Abstract
Tumor necrosis factor alpha (TNF-α) is a pro-inflammatory cytokine active in the bodily immune response and serious inflammatory diseases. Traditional ligands targeting TNF-α focus on antibodies and receptors, which always associate with low efficacy and specificity. In the present study, two peptide ligands (T1: Ac-RKEM-NH2 and T2: Ac-RHCLS-NH2) were designed by computer simulation technology considering the weak interactions between TNF-α and its receptor TNFR1. Calculations of binding free energy (BFE) were made by the Molecular Mechanics Poisson-Boltzmann Surface Area (MM-PBSA) method between T1 or T2 and TNF-α (-22.68 and -14.23 kcal mol-1, respectively). To assess the affinity levels, short peptide ligands were fixed on polyvinyl alcohol (PVA) microspheres; adsorption tests showed a stronger affinity of both PVA-T1 and PVA-T2 to TNF-α in PBS buffer than PVA microspheres (79.20 ± 1.32 and 74.27 ± 1.10 vs. 39.03 ± 1.25 pg mg-1, respectively). Moreover, PVA-T1 (74.8%, 17.60 ± 2.98 pg mg-1) and PVA-T2 (63.2%, 15.30 ± 4.81 pg mg-1) exhibit significantly enhanced TNF-α adsorption from the plasma of rats with sepsis to blank PVA and commercial XAD-7 resin. In conclusion, our results show that T1 designed by computer-aided molecular design (CAMD) exhibits a stronger affinity to TNF-α and it can significantly enhance PVA microsphere adsorption efficiency of TNF-α in plasma.
AuthorsJie Chen , Jixue Sun , Wenyan Han , Jian Chen , Weichao Wang , Guanghui Cheng , Jianping Lin , Nan Ma , Hao Chen , Lailiang Ou , Wenzhong Li
JournalJournal of materials chemistry. B (J Mater Chem B) Vol. 6 Issue 26 Pg. 4368-4379 (Jul 14 2018) ISSN: 2050-7518 [Electronic] England
PMID32254512 (Publication Type: Journal Article)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: